Literature DB >> 18752644

Effects of gamma-secretase cleavage-region mutations on APP processing and Abeta formation: interpretation with sequential cleavage and alpha-helical model.

Jianxin Tan1, Guozhang Mao, Mei-Zhen Cui, Shin-Chung Kang, Bruce Lamb, Boon-Seng Wong, Man-Sun Sy, Xuemin Xu.   

Abstract

Overwhelming evidence supports the amyloid hypothesis of Alzheimer's disease that stipulates that the relative level of the 42 amino acid beta-amyloid peptide (Abeta(42)) in relationship to Abeta(40) is critical to the pathogenesis of the disease. While it is clear that the multi-subunit gamma secretase is responsible for cleavage of the amyloid precursor protein (APP) into Abeta(42) and Abeta(40), the exact molecular mechanisms regulating the production of the various Abeta species remain elusive. To elucidate the underlying mechanisms, we replaced individual amino acid residues from positions 43 to 52 of Abeta with phenylalanine to examine the effects on the production of Abeta(40) and Abeta(42). All mutants, except for V50F, resulted in a decrease in total Abeta with a more prominent reduction in Abeta for residues 45, 48, and 51, following an every three residue repetition pattern. In addition, the mutations with the strongest reductions in total Abeta had the largest increases in the ratio of Abeta(42)/Abeta(40). Curiously, the T43F, V44F, and T48F mutations caused a striking decrease in the accumulation of membrane bound Abeta(46), albeit by a different mechanism. Our data suggest that initial cleavage of APP at the epsilon site is crucial in the generation of Abeta. The implicated sequential cleavage and an alpha-helical model may lead to a better understanding of the gamma-secretase-mediated APP processing and may also provide useful information for therapy and drug design aimed at altering Abeta production.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18752644      PMCID: PMC4633302          DOI: 10.1111/j.1471-4159.2008.05643.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  16 in total

1.  gamma-Cleavage is dependent on zeta-cleavage during the proteolytic processing of amyloid precursor protein within its transmembrane domain.

Authors:  Guojun Zhao; Mei-Zhen Cui; Guozhang Mao; Yunzhou Dong; Jianxin Tan; Longsheng Sun; Xuemin Xu
Journal:  J Biol Chem       Date:  2005-09-12       Impact factor: 5.157

2.  Peptidomimetic probes and molecular modeling suggest that Alzheimer's gamma-secretase is an intramembrane-cleaving aspartyl protease.

Authors:  M S Wolfe; W Xia; C L Moore; D D Leatherwood; B Ostaszewski; T Rahmati; I O Donkor; D J Selkoe
Journal:  Biochemistry       Date:  1999-04-13       Impact factor: 3.162

3.  On the size of the active site in proteases. I. Papain.

Authors:  I Schechter; A Berger
Journal:  Biochem Biophys Res Commun       Date:  1967-04-20       Impact factor: 3.575

4.  The profile of soluble amyloid beta protein in cultured cell media. Detection and quantification of amyloid beta protein and variants by immunoprecipitation-mass spectrometry.

Authors:  R Wang; D Sweeney; S E Gandy; S S Sisodia
Journal:  J Biol Chem       Date:  1996-12-13       Impact factor: 5.157

5.  Identification of a new presenilin-dependent zeta-cleavage site within the transmembrane domain of amyloid precursor protein.

Authors:  Guojun Zhao; Guozhang Mao; Jianxin Tan; Yunzhou Dong; Mei-Zhen Cui; Seong-Hun Kim; Xuemin Xu
Journal:  J Biol Chem       Date:  2004-10-13       Impact factor: 5.157

6.  A presenilin dimer at the core of the gamma-secretase enzyme: insights from parallel analysis of Notch 1 and APP proteolysis.

Authors:  Eric H Schroeter; Ma Xenia G Ilagan; Anne L Brunkan; Silva Hecimovic; Yue-ming Li; Min Xu; Huw D Lewis; Meera T Saxena; Bart De Strooper; Archie Coonrod; Taisuke Tomita; Takeshi Iwatsubo; Chad L Moore; Alison Goate; Michael S Wolfe; Mark Shearman; Raphael Kopan
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-17       Impact factor: 11.205

Review 7.  The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.

Authors:  John Hardy; Dennis J Selkoe
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

8.  Metabolism of the "Swedish" amyloid precursor protein variant in neuro2a (N2a) cells. Evidence that cleavage at the "beta-secretase" site occurs in the golgi apparatus.

Authors:  G Thinakaran; D B Teplow; R Siman; B Greenberg; S S Sisodia
Journal:  J Biol Chem       Date:  1996-04-19       Impact factor: 5.157

9.  Amyloid-like properties of peptides flanking the epitope of amyloid precursor protein-specific monoclonal antibody 22C11.

Authors:  C Hilbich; U Mönning; C Grund; C L Masters; K Beyreuther
Journal:  J Biol Chem       Date:  1993-12-15       Impact factor: 5.157

10.  Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein.

Authors:  A Weidemann; G König; D Bunke; P Fischer; J M Salbaum; C L Masters; K Beyreuther
Journal:  Cell       Date:  1989-04-07       Impact factor: 41.582

View more
  9 in total

1.  Nicastrin is required for amyloid precursor protein (APP) but not Notch processing, while anterior pharynx-defective 1 is dispensable for processing of both APP and Notch.

Authors:  Chen Hu; Linlin Zeng; Ting Li; Michael A Meyer; Mei-Zhen Cui; Xuemin Xu
Journal:  J Neurochem       Date:  2016-01-17       Impact factor: 5.372

2.  Dual-tagged amyloid-β precursor protein reveals distinct transport pathways of its N- and C-terminal fragments.

Authors:  Christine Villegas; Virgil Muresan; Zoia Ladescu Muresan
Journal:  Hum Mol Genet       Date:  2013-11-07       Impact factor: 6.150

3.  Overexpression of SOD-2 reduces hippocampal superoxide and prevents memory deficits in a mouse model of Alzheimer's disease.

Authors:  Cynthia A Massaad; Taneasha M Washington; Robia G Pautler; Eric Klann
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-03       Impact factor: 11.205

4.  Beta-amyloid precursor protein mutants respond to gamma-secretase modulators.

Authors:  Richard M Page; Amelie Gutsmiedl; Akio Fukumori; Edith Winkler; Christian Haass; Harald Steiner
Journal:  J Biol Chem       Date:  2010-03-26       Impact factor: 5.157

5.  Lysophosphatidic acid induces increased BACE1 expression and Aβ formation.

Authors:  Jing Shi; Yunzhou Dong; Mei-Zhen Cui; Xuemin Xu
Journal:  Biochim Biophys Acta       Date:  2012-10-02

Review 6.  BACE and gamma-secretase characterization and their sorting as therapeutic targets to reduce amyloidogenesis.

Authors:  Neville Marks; Martin J Berg
Journal:  Neurochem Res       Date:  2009-09-17       Impact factor: 3.996

7.  Residues at P2-P1 positions of epsilon- and zeta-cleavage sites are important in formation of beta-amyloid peptide.

Authors:  Jianxin Tan; Guozhang Mao; Mei-Zhen Cui; Bruce Lamb; Man-Sun Sy; Xuemin Xu
Journal:  Neurobiol Dis       Date:  2009-08-27       Impact factor: 5.996

8.  Major carboxyl terminal fragments generated by γ-secretase processing of the Alzheimer amyloid precursor are 50 and 51 amino acids long.

Authors:  Inga Pinnix; Jorge A Ghiso; Miguel A Pappolla; Kumar Sambamurti
Journal:  Am J Geriatr Psychiatry       Date:  2013-05       Impact factor: 4.105

9.  Salvianolic Acid B Inhibits Aβ Generation by Modulating BACE1 Activity in SH-SY5Y-APPsw Cells.

Authors:  Ying Tang; Dan Huang; Mei-Hua Zhang; Wen-Sheng Zhang; Yu-Xin Tang; Zheng-Xiang Shi; Li Deng; Dai-Han Zhou; Xin-Yi Lu
Journal:  Nutrients       Date:  2016-06-01       Impact factor: 5.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.